Abstract
Objective: In the present study, the essential oil of Athroisma proteiformis was characterized for the first time.
Method: GC-HRMS (Gas Chromatography-High Resolution Mass Spectrometry) was performed for qualitative and quantitative analysis of the phytochemicals present in the extract. Chemical analyses were conducted to evaluate the total phenols, total flavonoids and antioxidant activity of the extract. Results: Of the 130 peaks detected, 50 were studied and 30 compounds were clearly identified. The main components of the extract were p-cymen-8-ol, the major compound (13.37%), followed by caryophyllene oxide (12.02%), o-cymene (7.79%), humulene epoxide II (7.62%) and limonene (7.35%). The essential oil of Athroisma proteiformis exhibited a good antioxidant activity. The Athroisma extract IC50 values were lower than those of the antioxidant standards used in the FRAP and ABTS tests, ascorbic acid and BHT, and lower than glutathione in the OH radical reducing power test. On the contrary, in the DPPH test, IC50 was higher for A. proteiformis than for ascorbic acid or BHT. Conclusion: It can be concluded that the A. proteiformis plant can be used as a source of natural antioxidants but the consequences on human health should first be carefully studied due to the large number of compounds present in the oil.Keywords: Antioxidant activity, Asteraceae, Athroisma proteiformis, caryophyllene oxide, essential oil, p-Cymen-8-ol.
The Natural Products Journal
Title:Chemical Characterization and Antioxidant Potential of Athroisma proteiformis Essential Oil
Volume: 7 Issue: 3
Author(s): Claudine Aimée Rasolohery, Boniface Erménegilde Ralaibia, Alicia Ayerdi Gotor, Franck Merlier, Rakotonirina Benja, Marcelle Rakotovao and Larbi Rhazi*
Affiliation:
- UniLaSalle BP 30313, Beauvais CEDEX,France
Keywords: Antioxidant activity, Asteraceae, Athroisma proteiformis, caryophyllene oxide, essential oil, p-Cymen-8-ol.
Abstract: Objective: In the present study, the essential oil of Athroisma proteiformis was characterized for the first time.
Method: GC-HRMS (Gas Chromatography-High Resolution Mass Spectrometry) was performed for qualitative and quantitative analysis of the phytochemicals present in the extract. Chemical analyses were conducted to evaluate the total phenols, total flavonoids and antioxidant activity of the extract. Results: Of the 130 peaks detected, 50 were studied and 30 compounds were clearly identified. The main components of the extract were p-cymen-8-ol, the major compound (13.37%), followed by caryophyllene oxide (12.02%), o-cymene (7.79%), humulene epoxide II (7.62%) and limonene (7.35%). The essential oil of Athroisma proteiformis exhibited a good antioxidant activity. The Athroisma extract IC50 values were lower than those of the antioxidant standards used in the FRAP and ABTS tests, ascorbic acid and BHT, and lower than glutathione in the OH radical reducing power test. On the contrary, in the DPPH test, IC50 was higher for A. proteiformis than for ascorbic acid or BHT. Conclusion: It can be concluded that the A. proteiformis plant can be used as a source of natural antioxidants but the consequences on human health should first be carefully studied due to the large number of compounds present in the oil.Export Options
About this article
Cite this article as:
Rasolohery Aimée Claudine, Ralaibia Erménegilde Boniface, Gotor Ayerdi Alicia, Merlier Franck, Benja Rakotonirina, Rakotovao Marcelle and Rhazi Larbi*, Chemical Characterization and Antioxidant Potential of Athroisma proteiformis Essential Oil, The Natural Products Journal 2017; 7 (3) . https://dx.doi.org/10.2174/2210315507666170102154445
DOI https://dx.doi.org/10.2174/2210315507666170102154445 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting
Current Molecular Pharmacology Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
Current Cancer Drug Targets Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers
Current Drug Metabolism Synthesis and Evaluation of Indole Based Molecules for Treatment of Oxidative Stress Related Diseases
Current Topics in Medicinal Chemistry The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design The ACE Insertion/Deletion Polymorphism and Risk of Cancer, a Review and Meta-Analysis of the Literature
Current Cancer Drug Targets Dendrimers in Therapy for Breast and Colorectal Cancer
Current Medicinal Chemistry A Brief Review of circRNA Biogenesis, Detection, and Function
Current Genomics HAMPT, A Novel Quadruple Drug Combination Designed for Cancer Metastatic Chemoprevention: From Hypothesis to Proof-of-concept
Current Cancer Drug Targets Axin PPI Networks: New Interacting Proteins and New Targets?
Current Topics in Medicinal Chemistry Editorial [(Drugs and the Upper and Lower Gastrointestinal Tract: From Inflammation To Malignancy)
Current Drug Metabolism Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients
Current Drug Targets Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Antitumor Activity, and Structure-activity Relationship of Some Benzo[a]pyrano[2,3-c]phenazine Derivatives
Combinatorial Chemistry & High Throughput Screening On the Power of Additional and Complex Chromosomal Aberrations in CML
Current Genomics Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
Current Cancer Therapy Reviews Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy
Current Pharmaceutical Design Current and Potential Use of Citrus Essential Oils
Current Organic Chemistry Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology